Genetic polymorphisms, chronic lymphocytic leukemia, and the future: are we there yet?

AUTOR(ES)

Caimi, Paolo F., Lima, Marcos de

FONTE

Rev. Bras. Hematol. Hemoter.

DATA DE PUBLICAÇÃO

2014-01

RESUMO

Documentos Relacionados

• Biomarkers in Alzheimer disease: are we there yet?
• Understanding the chemistry of chemical communication: Are we there yet?
• Stem-cell therapy for hearing loss: are we there yet?
• Polygenic risk scores and their potential clinical use in psychiatry: are we there yet?
• Screening mammography for women aged 40–49: Are we off the fence yet?